Pulse Biosciences slips despite Q4 beat after deal to sell shares
Source: SeekingAlpha
2026-02-20 10:22:02 ET
More on Pulse Biosciences
- Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
- Pulse Biosciences, Inc. (PLSE) Presents at 31st Annual AF Symposium 2026 - Slideshow
- Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones
- Seeking Alpha’s Quant Rating on Pulse Biosciences
Read the full article on Seeking Alpha
For further details see:
Pulse Biosciences slips despite Q4 beat after deal to sell shares
Pulse Biosciences Inc
NASDAQ: PLSE
PLSE Trading
-1.04% G/L:
$18.05 Last:
69,356 Volume:
$18 Open:
PLSE Latest News
March 05, 2026 07:00:00 am
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 04, 2026 07:00:00 am
Pulse Biosciences' nPulse(TM) Vybrance(TM) System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
February 20, 2026 07:00:00 am
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
February 19, 2026 04:05:00 pm
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
PLSE Stock Data
$1,654,206,579
17,212,965
N/A
28
N/A
Medical Equipment & Supplies
Healthcare
US
Miami
